序号 | 专利名 | 申请号 | 申请日 | 公开(公告)号 | 公开(公告)日 | 发明人 |
---|---|---|---|---|---|---|
1 | 使用酸处理的乳清蛋白提取物水溶液治疗过敏症 | CN201080055545.2 | 2010-10-14 | CN102638996A | 2012-08-15 | 伊尔梅利·奥利·潘提拉; 伊恩·罗伯特·米切尔 |
本发明涉及乳清蛋白提取物的制造、涉及婴儿配方奶粉并涉及减少或预防食物过敏。这种乳清蛋白提取物是从一种含乳清蛋白的组合物通过以下步骤生产的:使一种含乳清蛋白的组合物与一种水溶液接触以形成一种样品,这种样品包括一种含可溶性蛋白的成分和一种不溶性成分;从该样品回收这种含可溶性蛋白的成分;并且将这种含可溶性蛋白的成分酸化,由此产生这种乳清蛋白提取物。通过本发明的方法生产的提取物可以用在作为膳食补充剂或食品的婴儿配方奶粉中。 | ||||||
2 | 加工乳的方法 | CN201480064754.1 | 2014-11-25 | CN105792657A | 2016-07-20 | H·卡里奥伊宁; J·帕尔蒂; J·埃斯凯利宁 |
本申请公开了加工乳的方法,其包含下述步骤:提供脱脂乳;分离脱脂乳,以提供两种或更多种级分;将所述两种或更多种级分中的一部分或全部提供到至少两种组合物中;将所述至少两种组合物进行至少一种减少微生物负载的处理,其中所述至少一种减少微生物负载的处理对于各组合物是不同的。还公开了生产乳制品的方法,其中乳制品至少由两种不同处理的组合物构成。 | ||||||
3 | 人乳渗透物组合物及其制备和使用方法 | CN200980155914.2 | 2009-12-02 | CN102300575A | 2011-12-28 | J.福尔尼尔; S.埃克; S.埃尔斯特; D.J.雷克特曼 |
本公开内容的特征在于自分级的人全乳获得的人乳渗透物和含有该人乳渗透物的组合物。本发明的富含寡糖的渗透物和渗透物组合物作为早产和足月婴儿的营养补充剂可用于建立或维持肠道菌群及用于治疗炎性肠病的症状。 | ||||||
4 | A METHOD FOR PROCESSING MILK | US15039215 | 2014-11-25 | US20170105424A1 | 2017-04-20 | Harri KALLIOINEN; Jukka PARTTI; Jukka ESKELINEN |
A method for processing milk, comprising the steps of: providing skim milk; separating the skim milk to provide two or more fractions; providing a part or all of the two or more fractions into at least two compositions; subjecting the at least two compositions to at least one microbial load reduction treatment, wherein the at least one microbial load reduction treatment is different for each composition, is disclosed. Also, a method for producing a milk product, wherein the milk product is composed at least from the two differently treated compositions is disclosed. | ||||||
5 | Human milk permeate compositions and methods of making and using same | US13132545 | 2009-12-02 | US08927027B2 | 2015-01-06 | Joseph Fournell; Scott Eaker; Scott Elster; David J. Rechtman |
This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease. | ||||||
6 | Method of processing a proteinous material, a product so obtained, and use thereof | US09806324 | 1999-09-29 | US06866879B1 | 2005-03-15 | Outi Vaarala; Olli Tossavainen; Outi Kerojoki; Kari Salminen; Marika Eriksson |
The invention relates to a method of removing bovine insulin from a liquid fat-free proteinous material originating from cow's milk, wherein the liquid fat-free proteinous material originating from cow's milk, the material having a pH of 2 to 8, at a temperature below 65° C., is contacted with an adsorption resin, whereby the weight ratio of the proteinous material to be treated to the adsorption resin is at most 100:1, optionally combining with said resin treatment at least one ultra and dia-filtration treatment of the proteinous material, and, if necessary, the liquid material so obtained is concentrated into a protein concentrate and optionally dried to powder. The invention further relates to a substantially bovine insulin-free proteinous material so obtained, and to its use as the protein part or raw material in the preparation of substantially bovine insulin-free infant formulae or other special nutritive preparations or consumption milk, other milk drinks or other milk preparations, or as a raw material therein. | ||||||
7 | Process for the recovery of immunoglobulins | US425099 | 1982-09-22 | US4490290A | 1984-12-25 | Mohamed M. Gani; Keith May; Philip Porter |
A process for the recovery of immunoglobulins of high purity and potency from milk, in which process milk is passed through a re-usable immunoadsorbent column comprising an insoluble carrier material to which is bound a low-affinity monoclonal antibody specific to one or more milk immunoglobulins but not specific to any other common constituent of milk, the antibody bind immunoglobulin molecules are released by eluting the immunoadsorbent. | ||||||
8 | Method for the separation of substances of different molecular sizes from a solution of said substances in a solvent | US3467595D | 1967-06-20 | US3467595A | 1969-09-16 | STEN ARNE O |
9 | 酸処理水性乳清タンパク質抽出物を使用したアレルギー治療 | JP2015223225 | 2015-11-13 | JP2016073294A | 2016-05-12 | ペンティラ,イルメリ アウリ; ミッチェル,イアン ロバート |
【課題】適切な免疫応答と発達を促進する為の乳清タンパク質抽出物の製造方法、乳児用調製粉乳、及び食物アレルギーの低減又は防止方法の提供。 【解決手段】乳清タンパク質含有組成物を水溶液と接触させて可溶性タンパク質含有構成要素と不溶性構成要素を含むサンプルを生成し、可溶性タンパク質含有構成要素をサンプルから回収し、可溶性タンパク質含有構成要素を酸性化し、乳清タンパク質抽出物を製造する。この乳清タンパク質抽出物は、乳児用調製粉乳、健康補助食品、食材、又は、食物アレルギーの低減、防止のための薬剤の製造にも使用することができる。 【選択図】なし |
||||||
10 | Human milk transmission compositions and methods of making and using the same | JP2011538734 | 2009-12-02 | JP2012510476A | 2012-05-10 | エーカー,スコット; エルスター,スコット; フォーネル,ジョセフ; レッチマン,デイビッド,ジェイ. |
本開示は、ヒト乳透過物と、分画したヒト全乳から得られるヒト乳透過物を含有する組成物とを特徴とする。 本発明のオリゴ糖の豊富な透過物および透過組成物は、腸管内菌叢を確立または維持するため、そして炎症性腸疾患の症状を治療するための早期および満期産児の栄養補充剤として有用である。 | ||||||
11 | JPS58500127A - | JP50070482 | 1982-02-24 | JPS58500127A | 1983-01-20 | |
12 | FOAMABLE MILK COMPOSITION | US15690490 | 2017-08-30 | US20180084796A1 | 2018-03-29 | Katja Borcherding |
Suggested is a foamable dairy composition, containing or consisting of: (a) at least one dairy product, and (b) an additive which is obtained by subjecting a dairy product to filtration, separating the permeate which is optionally subjected to a thermal post-treatment. | ||||||
13 | Allergy treatment using acid treated aqueous whey protein extract | US13501819 | 2010-10-14 | US09066526B2 | 2015-06-30 | Irmeli Auli Penttila; Ian Robert Mitchell |
The invention relates to manufacture of whey protein extracts, to infant formula and to reducing or preventing food allergy. The whey protein extract is produced from a whey protein-containing composition by contacting a whey protein-containing composition with an aqueous solution to form a sample including a soluble protein-containing component and an insoluble component; recovering the soluble protein-containing component from the sample; and acidifying the soluble protein-containing component, thereby producing the whey protein extract. Extracts produced by the method of the invention may be used in infant formula, as a dietary supplement or foodstuff. | ||||||
14 | ALLERGY TREATMENT USING ACID TREATED AQUEOUS WHEY PROTEIN EXTRACT | US13501819 | 2010-10-14 | US20120201839A1 | 2012-08-09 | Irmeli Penttla; Ian Robert Mitchell |
The invention relates to manufacture of whey protein extracts, to infant formula and to reducing or preventing food allergy. The whey protein extract is produced from a whey protein-containing composition by contacting a whey protein-containing composition with an aqueous solution to form a sample including a soluble protein-containing component and an insoluble component; recovering the soluble protein-containing component from the sample; and acidifying the soluble protein-containing component, thereby producing the whey protein extract. Extracts produced by the method of the invention may be used in infant formula, as a dietary supplement or foodstuff. | ||||||
15 | HUMAN MILK PERMEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME | US13132545 | 2009-12-02 | US20110256233A1 | 2011-10-20 | Joseph Fournell; Scott Eaker; Scott Elster; David J. Rechtman |
This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease. | ||||||
16 | Chromatographic fractionation of whey | US455484 | 1974-03-27 | US3969337A | 1976-07-13 | Karl Lauer; Georg Stoeck; Friedrich Batz |
The process for the chromatographic fractionation of whey comprising passing whey through a column of an ion exchange material, thereafter passing water through said column as eluant, and collecting the aqueous effluent from said column as a plurality of fractions. Advantageously the ion exchange material is a polystyrene resin containing sulfonic acid groups neutralized with calcium ions and cross-linked with about 2 to 4% by weight of divinyl-benzene, and the eluant is demineralized water. | ||||||
17 | Elution volume | US27806D | 1971-09-27 | USRE27806E | 1973-10-30 | |
A PROCESS FOR THE EFFICIENT SEPARATION OF DISSOLVED PROTEIN FROM AN AQUEOUS SOLUTION CONTAINING DISSOLVED MATERIAL OF LOWER MOLECULAR WEIGHT, USING A MOLECULAR SIEVE BED WITH A THICKNESS BETWEEN ABOUT 10 AND 100 MILLIMETERS AND A FEED SOLUTION VOLUME UP TO AS MUCH AS 65 PERCENT OF THE TOTAL BED VOLUME.
|
||||||
18 | Molecular fractionation by pulsed centrifugation | US3664845D | 1970-11-25 | US3664845A | 1972-05-23 | FRIEDMAN HERMAN H |
A MEANS FOR THE RAPID, EFFICIENT FRACTIONATION OF WATER SOUBLE SUBSTANCES BY MEANS OF PASSAGE THROUGH A MOLECULAR FRACTIONATING GEL HAS BEEN DEVELOPED WHICH EMPLOYS A PULSED CENTRIFUGATION TECHNIQUE. THIS DEVELOPMENT IS A USEFUL FOOD PROCESSING OPERATION TO QUICKLY AND EFFICIENTLY SEPARATE VALUABLE FOOD COMPONENTS SUCH AS FLAVORS AND PROTEINS FROM AQUEOUS SOLUTIONS SUCH AS COFFEE EXTRACT AND WHEY.
|
||||||
19 | Method for the manufacture of a concentrate of a bifidogen factor | US3556801D | 1967-01-18 | US3556801A | 1971-01-19 | HOSTETTLER HERMANN GUSTAV |
THIS INVENTION RELATES TO A METHOD FOR THE MANUFACTURE OF A BIFIDOGEN FACTOR CALLED "BIFIDUS 2" (BF2) WITH ENHANCED ACTIVITY. THE PROCESS OF THE INVENTION IS CHARACTERIZED BY PASSING A PROTEIN HYDROLYSATE CONTAINING THE FACTOR BF2 AT LEAST TWOCE THROUGH A CHROMATOGRAPHIC COLUMN OF AN ION-EXCHANGE RESIN OR THROUGH A DEXTRAN GEL. THE FIRST CHROMATOGRAPHY IS CHARACTERIZED BY PASSING THE HYDROLYSATE THROUGH A COLUMN OF A STRONG ACID CATION EXCHANGE RESIN IN THE ACID FORM. THE SECOND CHROMATOGRAPHY IS CHARACTERIZED BY PASSING THE CONCENTRATED ELUATE FROM THE FIRST CHROMATOGRAPHY PROCESS THROUGH A COLUMN OF A WEAK ACID CATION EXCHANGE RESIN. THE BF2 CONCENTRATE IS THEN OBTAINED BY A FURTHER CHROMATOGRAPHIC PROCESS USING A BASIC ANION EXCHANGE RESIN, OR FILTERING THE SOLUTION THROUGH GEL. THE PROCESS IS DIRECTED TOWARDS OBTAINING AN IMPROVEMENT IN THE YIELD OF BF2 CONCENTRATE FROM PROTEIN HYDROLYSATE SOLUTION.
|
||||||
20 | Process for separating protein from aqueous solutions containing dissolved material of lower molecular weight using a thin bed of molecular sieve material | US3547900D | 1969-03-18 | US3547900A | 1970-12-15 | DIENST CARL S; ATTEBERY JERRY M |